In a special meeting Aug. 11, shareholders of CardioDynamics approved the company’s merger with hand-carried ultrasound pioneer SonoSite.
CardioDynamics set to join SonoSite
In a special meeting Aug. 11, shareholders of CardioDynamics approved the company’s merger with hand-carried ultrasound pioneer SonoSite. Under the $10 million cash deal, they will receive $1.35 per share, representing a 69% premium over the closing share price on June 8, 2009, the day before the definitive merger agreement was announced. The shareholder vote clears the way for CardioDynamics, which makes the BioZ impedance cardiography technology, to join SonoSite as a wholly owned subsidiary. The technology helps diagnose and assess high blood pressure and ventricular function.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.